Overview

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).
Phase:
Phase 3
Details
Lead Sponsor:
Padagis LLC
Perrigo Company
Treatments:
Benzoyl Peroxide
Clindamycin
Clindamycin palmitate
Clindamycin phosphate